Urinary sulfated bile acid analysis for the early detection of biliary atresia in infants

Pediatrics International

Volumn 53, Issue 4, 2011, Pages 497-500

  Suzuki, Mitsuyoshi ^a   Muraji, Toshihiro ^b   Obatake, Masayuki ^c   Nio, Masaki ^d   Ito, Kiichi ^e   Suzuki, Ken ^f   Ota, Kunitaka ^g   Maisawa, Shunichi ^h   Yamashiro, Yuichiro ^a   Shimizu, Toshiaki ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Ibaraki Children's Hospital   (Japan)

^c NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

^d TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e DAITO BUNKA UNIVERSITY   (Japan)

^f Tokyo Association of Health Service   (Japan)

^g Konan Hospital Foundation Rokko Island Hospital   (Japan)

^h Morioka Children's Hospital   (Japan)

Author keywords

biliary atresia; hepatoportoenterostomy; jaundice; urinary sulfated bile acid

Indexed keywords

BILE ACID; CREATININE; UNCLASSIFIED DRUG; URINARY SULFATED BILE ACID;

ARTICLE; ASSAY; AUTOANALYZER; BILE DUCT ATRESIA; BILIARY TRACT SURGERY; CHOLANGIOGRAPHY; CHOLESTASIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC KIT; EARLY DIAGNOSIS; FEMALE; HEPATOPORTOENTEROSTOMY; HUMAN; INFANT; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; NEWBORN; NEWBORN SCREENING; NON INVASIVE PROCEDURE; PREDICTIVE VALUE; PRIORITY JOURNAL; SCREENING TEST; URINALYSIS;

BILE ACIDS AND SALTS; BILIARY ATRESIA; BIOLOGICAL MARKERS; CREATININE; EARLY DIAGNOSIS; FEASIBILITY STUDIES; FOLLOW-UP STUDIES; HUMANS; INFANT; INFANT, NEWBORN; NEONATAL SCREENING; PILOT PROJECTS;

EID: 80051991656     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/j.1442-200X.2010.03268.x     Document Type: Article

References (21)

1. Nio M, Ohi R, Miyano T, Saeki M, Shiraki K, Tanaka K,. Five- and 10-year survival rates after surgery for biliary atresia: A report from the Japanese Biliary Atresia Registry. J. Pediatr. Surg. 2003; 38: 997-1000. (Pubitemid 36828861)
2. The Japanese Biliary Atresia Society and Department of Biliary Atresia Nationwide Registry. Summary of Japanese Biliary Atresia Registry from 1989 to 2006. J. Jpn. Soc. Pediatr. Surg. 2008; 44: 167-76.
3. Mieli-Vergani G, Howard ER, Portman B, Mowat AP,. Late referral for biliary atresia-missed opportunities for effective surgery. Lancet 1989; 1: 421-23. (Pubitemid 19059160)
4. Simko V, Michael S,. Urinary bile acids in population screening for inapparent liver disease. Hepatogastroenterology 1998; 45: 1706-14. (Pubitemid 28515187)
5. Obatake M, Muraji T, Satoh S, Nishijima E, Tsugawa C,. Urinary sulfated bile acids: A new simple urine test for cholestasis in infants and children. J. Pediatr. Surg. 2002; 37: 1707-8. (Pubitemid 35416918)
6. Matsui A, Kasano Y, Yamauchi Y, et al,. Direct enzymatic assay of urinary sulfated bile acids to replace serum bilirubin testing for selective screening of neonatal cholestasis. J. Pediatr. 1996; 129: 306-8. (Pubitemid 27483807)
7. Muraji T, Harada T, Miki K, Moriuchi T, Obatake M, Tsugawa C,. Urinary sulfated bile acid concentrations in infants with biliary atresia and breast-feeding jaundice. Pediatr. Int. 2003; 45: 281-3. (Pubitemid 36995098)
8. Hiyama E, Iehara T, Sugimoto T, et al,. Effectiveness of screening for neuroblastoma at 6 months of age: A retrospective population-based cohort study. Lancet 2008; 371: 1173-80. (Pubitemid 351458522)
9. Obatake M,. New strategy for the early diagnosis of biliary atresia using urine sulfated bile acid. Jpn. J. Pediatr. Surg. 2008; 40: 56-60.
10. Tazuke Y, Matsuda K, Adachi K, Tsukada Y,. Purification and properties of bileacid sulfate sulfatase from Pseudomonas testosteroni. Biosci. Biotechnol. Biochem. 1994; 58: 889-94. (Pubitemid 2108807)
11. Tazuke Y, Kodama N, Adachi K, et al,. A new enzymatic assay method of sulfated bile acids in urine. Jpn. J. Clin. Chem. 1992; 21: 249-58. (Pubitemid 23043146)
12. Matsui A, Dodoriki M,. Screening for biliary atresia. Lancet 1995; 345: 1181.
13. Hsiao CH, Chang MH, Chen HL, et al,. Universal screening for biliary atresia using an infant stool color card in Taiwan. Hepatology 2007; 47: 1233-40.
14. Keffler S, Kelly DA, Powell JE, Green A,. Population screening for neonatal liver disease: A feasibility study. J. Pediatr. Gastroenterol. Nutr. 1998; 27: 306-11. (Pubitemid 28430861)
15. Powell JE, Keffler S, Kelly DA, Green A,. Population screening for neonatal liver disease: Potential for a community-based programme. J. Med. Screen. 2003; 10: 112-6. (Pubitemid 38296845)
16. Sokol RJ, Shepherd RW, Superina R, Bezerra JA, Robuck P, Hoofnagle JH,. Screening and outcomes in biliary atresia: Summary of a National Institutes of Health workshop. Hepatology 2007; 46: 566-81. (Pubitemid 47344793)
17. Sokol RJ, Mack C,. Etiopathogenesis of biliary atresia. Semin. Liver Dis. 2001; 21: 517-24. (Pubitemid 33131043)
18. Muraji T, Hosaka N, Irie N, et al,. Maternal microchimerism in underlying pathogenesis of biliary atresia: Quantification and phenotypes of maternal cells in the liver. Pediatrics 2008; 121: 517-21.
19. Hisashige A,. Health economic analysis of the neonatal screening program in Japan. Int. J. Technol. Assess. Health Care 1994; 10: 382-91. (Pubitemid 24222538)
20. Pang SY, Wallace MA, Hofman L,. Worldwide experience in newborn screening for classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Pediatrics 1988; 81: 866-74.
21. Toublanc JE,. Comparison of epidemiological data on congenital hypothyroidism in Europe with those of other parts in the world. Horm. Res. 1992; 38: 230-35.